Skip to Main Content

Paper Details

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
Clinical Cancer Research
117
2018
CAR T cells, CS1, CS1 CAR, CS1 CAR T cells, CS1 Chimeric Antigen Receptor, CS1 Chimeric Antigen Receptor-Redirected T Cells, CS1-directed CAR T cells, Lenalidomide, Multiple Myeloma, Multiple myeloma, Th1 cytokine, central memory T cells, chimeric, engineered T cells, lenalidomide, malignancy of plasma cells, mice, multiple myeloma, multiple myeloma tumor, myeloma
Author NameAffiliation
Amrita Krishnan
Amrita KrishnanJudy and Bernard Briskin Center for Multiple Myeloma
  • 1 - 2

Datasets

Release 1.2